샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777478

세계의 조산 및 PROM 검사 시장

Preterm Birth and PROM Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 293 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조산 및 PROM 검사 시장은 2030년까지 23억 달러에 이를 전망

2024년에 15억 달러로 추정되는 조산 및 PROM 검사 세계 시장은 분석 기간인 2024-2030년 CAGR 7.4%로 성장하여 2030년에는 23억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 골반 검사는 CAGR 8.8%를 나타내고, 분석 기간 종료시에는 7억 170만 달러에 이를 것으로 예측됩니다. 태아 피브로넥틴 검사 부문의 성장률은 분석 기간중 CAGR 8.1%로 추정됩니다.

미국 시장은 추정 4억 500만 달러, 중국은 CAGR11.7%로 성장 예측

미국의 조산 및 PROM 검사 시장은 2024년에 4억 500만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 11.7%로 2030년까지 4억 8,590만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.6%와 7.2%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.9%를 나타낼 전망입니다.

세계 조산 및 PROM 검사 시장 - 주요 동향 및 촉진요인 요약

조산 및 PROM 검사는 어떻게 산모-신생아 관리를 개선하고 있는가?

조산 및 조기양막파수(PROM) 검사는 태아의 발육과 신생아 생존에 영향을 미치는 합병증을 조기에 진단하고 위험도를 평가할 수 있어 임산부 건강관리에 필수적인 도구가 되고 있습니다. 조산은 임신 37주 이전의 분만으로 정의되며, 전 세계적으로 신생아 사망률과 이환율의 주요 원인 중 하나입니다. 조기 양막파열(진통이 시작되기 전에 양막낭이 자연적으로 파열되는 것)은 감염, 조산, 신생아 합병증의 위험을 현저히 증가시킵니다. 바이오마커 기반 분석, 태아 피브로넥틴(fFN) 검사, 현장진단(POC) 검사 솔루션과 같은 첨단 진단법은 임상의가 조산을 예측하고 관리하는 방식을 바꾸고 있습니다. 산부인과 의료에서 신속한 진단 도구의 통합은 더 나은 의사결정, 적시 개입, 더 나은 임신 결과를 가져옵니다. 의료 시스템이 조산율 감소와 신생아 생존율 향상에 초점을 맞추고 있는 가운데, 조산 및 PROM 검사는 산부인과 병원, 클리닉, 고위험 임신 모니터링 프로그램에 필수적인 요소로 자리 잡고 있습니다.

조산 및 PROM 검사 도입에 영향을 미치는 과제는?

그 중요성에도 불구하고 조산 및 PROM 검사의 채택은 시장 확대와 접근성에 영향을 미치는 몇 가지 과제에 직면해 있습니다. 주요 관심사 중 하나는 고급 진단 검사와 관련된 비용이며, 임산부 건강 관리 인프라가 제한적인 저자원 환경에서는 접근성이 떨어집니다. 또한, 검사 정확도의 편차와 위양성률은 불필요한 입원, 스테로이드 및 약물 투여, 의료비 증가로 이어질 수 있습니다. 이러한 검사를 보편적으로 시행할 수 있는 표준화된 가이드라인이 없기 때문에 조산 위험 관리를 위한 프로토콜이 의료 시스템마다 다르기 때문에 임상적 의사결정이 더욱 복잡해집니다. 또 다른 문제는 조산과 PROM 검사에 대한 임산부들의 인식이 제한적이어서 진단과 개입이 늦어지고 있다는 점입니다. 또한, 규제 당국의 승인과 엄격한 임상 검증 요건으로 인해 혁신적인 검사 솔루션의 상용화가 지연되고 시장 보급이 늦어지고 있습니다. 이러한 문제를 해결하기 위해서는 지속적인 연구, 비용 효율적인 검사 개발, 의료진과 환자 교육을 강화하기 위한 타겟팅된 교육 캠페인이 필요합니다.

진단기술의 혁신은 어떻게 변화하고 있는가조산 및 PROM 검사법

모체 태아 진단의 기술 발전은 조산 및 PROM 검사에 혁명을 일으켜 정확성, 효율성, 접근성을 향상시키고 있습니다. 태반 α-마이크로글로불린-1(PAMG-1), 인슐린 유사 성장인자 결합 단백질-1(IGFBP-1)과 같은 비침습적 바이오마커 기반 검사법의 개발로 PROM을 높은 민감도와 특이성으로 검출할 수 있는 능력이 향상되었습니다. AI를 활용한 예측 분석과 머신러닝 알고리즘도 임산부 건강 모니터링에 통합되고 있으며, 임상의가 환자의 병력, 생리적 데이터, 실시간 바이오마커 추적을 통해 조산 위험을 평가할 수 있게 되었습니다. 휴대용 검사 장비와 현장 검사 장비는 원격지나 저개발 지역에서의 진단을 보다 쉽게 할 수 있게 하고, 위험 임신에 대한 조기 개입을 가능하게 합니다. 원격의료와 디지털 헬스 플랫폼의 등장으로 조산 진단의 보급은 더욱 확산되고 있으며, 임산부들은 실시간 상담과 개인별 위험도 평가에 접근할 수 있게 되었습니다. 산과 의료에서 정밀의료가 확산됨에 따라 조산 및 PROM 검사는 더욱 정교해져 산전 치료 전략과 주산기 예후를 개선할 수 있을 것으로 예측됩니다.

조산 및 PROM 검사 시장의 성장 원동력은?

조산 및 PROM 검사 시장의 성장은 전 세계 조산율 증가, 산모 건강 관리 진단의 발전, 현장 검사 솔루션의 채택 증가 등 여러 요인에 의해 주도되고 있습니다. 신생아 사망률과 이환율 감소에 대한 관심이 높아지면서 조기에 정확한 조산 감지법에 대한 수요가 가속화되고 있으며, 혁신적인 진단 기술에 대한 투자가 증가하고 있습니다. 모체태아의학 프로그램과 고위험 임신 클리닉의 확대는 의료 서비스 제공업체들이 조기 검진 및 중재 전략을 우선순위에 두면서 시장 성장을 더욱 촉진하고 있습니다. 또한, 임산부 건강 개선을 위한 정부의 이니셔티브와 자금 지원은 공공 의료 시스템에서 첨단 검사 솔루션의 채택을 촉진하고 있습니다. 헬스케어의 급속한 디지털화와 임신 모니터링에 AI의 통합은 보다 정확하고 사용하기 쉬운 위험 평가 도구를 가능하게 하여 새로운 시장 기회를 창출하고 있습니다. 개인화된 산모 건강 관리에 대한 수요가 지속적으로 증가함에 따라 조산 및 PROM 검사 시장은 지속적인 성장세를 보이며 조기 진단과 표적화된 개입을 통해 산모 관리를 변화시킬 것으로 예측됩니다.

부문

검사 유형(골반 검사 검사, 초음파 검사, 생화학 표지자 검사, 자궁 모니터링 검사, 니타진 검사, 퍼닝 검사, 풀링 검사, PAMG-1 면역 분석 검사, IGFBP 검사, 태아 피브로넥틴 검사, 기타 검사 유형); 신청(PROM 신청, 조기 진통 신청, 융모양막염 신청); 신청(조기 양수 검사, 양수 검사, 융모막염 신청)

조사 대상 기업 예

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.01

Global Preterm Birth and PROM Testing Market to Reach US$2.3 Billion by 2030

The global market for Preterm Birth and PROM Testing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Pelvic Exam Test, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$701.7 Million by the end of the analysis period. Growth in the Fetal Fibronectin Test segment is estimated at 8.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$405.0 Million While China is Forecast to Grow at 11.7% CAGR

The Preterm Birth and PROM Testing market in the U.S. is estimated at US$405.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$485.9 Million by the year 2030 trailing a CAGR of 11.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Preterm Birth and PROM Testing Market - Key Trends & Drivers Summarized

How Is Preterm Birth and PROM Testing Improving Maternal and Neonatal Care?

Preterm birth and premature rupture of membranes (PROM) testing have become essential tools in maternal healthcare, enabling early diagnosis and risk assessment for complications that can impact fetal development and neonatal survival. Preterm birth, defined as delivery before 37 weeks of gestation, is one of the leading causes of neonatal mortality and morbidity worldwide. Premature rupture of membranes, the spontaneous breaking of the amniotic sac before labor begins, significantly increases the risk of infection, preterm delivery, and neonatal complications. Advanced diagnostic methods, including biomarker-based assays, fetal fibronectin (fFN) tests, and point-of-care (POC) testing solutions, are transforming the way clinicians predict and manage preterm labor. The integration of rapid diagnostic tools in obstetric care has led to improved decision-making, timely interventions, and better pregnancy outcomes. As healthcare systems focus on reducing preterm birth rates and improving neonatal survival, preterm birth and PROM testing are becoming indispensable in maternity hospitals, clinics, and high-risk pregnancy monitoring programs.

What Challenges Are Affecting the Adoption of Preterm Birth and PROM Testing?

Despite its importance, the adoption of preterm birth and PROM testing faces several challenges that impact market expansion and accessibility. One of the primary concerns is the cost associated with advanced diagnostic tests, making them less accessible in low-resource settings where maternal healthcare infrastructure is limited. Additionally, the variability in test accuracy and false-positive rates can lead to unnecessary hospitalizations, administration of steroids or tocolytics, and increased healthcare costs. The lack of standardized guidelines for the universal implementation of these tests further complicates clinical decision-making, as different healthcare systems adopt varying protocols for managing preterm labor risk. Another challenge is the limited awareness among expectant mothers regarding the availability of preterm birth and PROM tests, leading to delayed diagnosis and intervention. Moreover, regulatory approvals and stringent clinical validation requirements slow down the commercialization of innovative testing solutions, delaying widespread market adoption. Addressing these challenges requires continuous research, cost-effective test development, and targeted awareness campaigns to enhance healthcare provider and patient education.

How Are Innovations in Diagnostic Technologies Transforming Preterm Birth and PROM Testing?

Technological advancements in maternal-fetal diagnostics are revolutionizing preterm birth and PROM testing, improving accuracy, efficiency, and accessibility. The development of non-invasive and biomarker-based assays, such as placental alpha-microglobulin-1 (PAMG-1) and insulin-like growth factor-binding protein-1 (IGFBP-1) tests, has enhanced the ability to detect PROM with high sensitivity and specificity. AI-powered predictive analytics and machine learning algorithms are also being integrated into maternal health monitoring, allowing clinicians to assess preterm birth risk using patient history, physiological data, and real-time biomarker tracking. Portable and point-of-care testing devices are making diagnostics more accessible in remote and underdeveloped regions, enabling early intervention in at-risk pregnancies. The rise of telemedicine and digital health platforms is further enhancing the reach of preterm birth diagnostics, allowing pregnant women to access real-time consultations and personalized risk assessments. As precision medicine gains traction in obstetric care, preterm birth and PROM testing are expected to become more sophisticated, enabling tailored treatment strategies and improved perinatal outcomes.

What Is Driving the Growth of the Preterm Birth and PROM Testing Market?

The growth in the preterm birth and PROM testing market is driven by several factors, including increasing global preterm birth rates, advancements in maternal healthcare diagnostics, and the rising adoption of point-of-care testing solutions. The growing focus on reducing neonatal mortality and morbidity has accelerated the demand for early and accurate preterm birth detection methods, leading to increased investment in innovative diagnostic technologies. The expansion of maternal-fetal medicine programs and high-risk pregnancy clinics has further fueled market growth, as healthcare providers prioritize early screening and intervention strategies. Additionally, government initiatives and funding for maternal health improvement are promoting the adoption of advanced testing solutions in public healthcare systems. The rapid digitalization of healthcare and the integration of AI in pregnancy monitoring are also creating new market opportunities, enabling more precise and accessible risk assessment tools. As demand for personalized maternal healthcare continues to rise, the preterm birth and PROM testing market is expected to experience sustained growth, transforming prenatal care through early diagnosis and targeted interventions.

SCOPE OF STUDY:

The report analyzes the Preterm Birth and PROM Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Pelvic Exam Test, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test, IGFBP Test, Fetal Fibronectin Test, Other Test Types); Application (PROM Application, Preterm Labor Application, Chorioamnionitis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Biosynex
  • Clinical Innovations, LLC
  • CooperSurgical Inc.
  • Creative Diagnostics
  • ELITechGroup
  • Hologic, Inc.
  • IQ Products
  • LifeCell International Pvt. Ltd.
  • Luminex Corporation
  • Medix Biochemica
  • Natera Inc.
  • NX Prenatal Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Randox Laboratories Ltd.
  • Sera Prognostics
  • SeraCare Life Sciences
  • The Cooper Companies Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Preterm Birth and PROM Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Preterm Births Throws the Spotlight on Early and Accurate Diagnostic Solutions
    • Growing Clinical Awareness Around Premature Rupture of Membranes (PROM) Drives Adoption of Specialized Testing Tools
    • Advancements in Biomarker-Based Diagnostic Platforms Spur Innovation in Rapid and Non-Invasive PROM Detection
    • Increased Emphasis on Risk Stratification and Preventive Obstetric Care Strengthens Business Case for Early PROM Screening
    • Expansion of Point-of-Care Testing Technologies Propels Growth in Decentralized and Immediate PROM Diagnosis
    • Rising Maternal Age and Associated Pregnancy Complications Drive Demand for Predictive Preterm Birth Testing
    • Integration of Molecular Diagnostic Techniques Enhances Sensitivity and Specificity of PROM and Preterm Risk Assessments
    • Growth in Hospital-Acquired Infection Control Programs Spurs Interest in Minimally Invasive and Accurate Testing Devices
    • Development of Amniotic Fluid-Specific Detection Reagents Generates Demand for Targeted PROM Identification Tools
    • Expansion of Neonatal Intensive Care Units (NICUs) Strengthens Investment in Prenatal Risk Management Solutions
    • Emergence of Multiplex Testing Panels Accelerates Adoption of Combined PROM and Preterm Birth Diagnostic Kits
    • Regulatory Endorsements and Clinical Guidelines Drive Standardization of PROM and Preterm Testing Protocols
    • Rising Penetration of Digital Health and Remote Monitoring Platforms Spurs Innovation in At-Home PROM Test Accessibility
    • Increased Collaboration Between Diagnostic Companies and Obstetric Research Institutes Propels Evidence-Based Product Development
    • Growing Health Infrastructure in Emerging Markets Expands Access to Low-Cost, High-Efficacy PROM Testing Solutions
    • Surge in Demand for Rapid Diagnostics in Emergency Obstetric Settings Drives Point-of-Care Market Momentum
    • Heightened Focus on Reducing Neonatal Morbidity and Mortality Strengthens Value Proposition of Early PROM Detection
    • Government Funding and Public Health Campaigns Targeting Maternal Health Accelerate PROM Testing Program Implementation
    • Adoption of AI-Enabled Diagnostic Algorithms Enhances Interpretation Accuracy and Decision Support in High-Risk Pregnancies
    • Rising Consumer Awareness of Maternal-Fetal Health Drives Uptake of PROM and Preterm Screening in Private Clinics
    • Increased Commercialization of Disposable Diagnostic Devices Supports Infection Control and Compliance in Hospital Settings
    • Challenges in Reimbursement for Newer PROM Testing Technologies Spur Innovation in Cost-Effective Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Preterm Birth and PROM Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Preterm Birth and PROM Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pelvic Exam Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pelvic Exam Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fetal Fibronectin Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Fetal Fibronectin Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ultrasound Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochemical Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochemical Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Uterine Monitoring Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Uterine Monitoring Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nitazine Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nitazine Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ferning Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ferning Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pooling Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pooling Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for PAMG-1 Immunoassay Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for PAMG-1 Immunoassay Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for IGFBP Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for IGFBP Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for PROM Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for PROM Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Preterm Labor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Preterm Labor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Chorioamnionitis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Chorioamnionitis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • CHINA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preterm Birth and PROM Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: UK 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 101: UK Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 104: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Spain Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 110: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Russia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 131: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Australia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • INDIA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 137: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: India Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: India 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 140: India Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 143: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: South Korea Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Preterm Birth and PROM Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 164: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Argentina Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 170: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Brazil Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 176: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Mexico Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Preterm Birth and PROM Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 197: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Iran Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 203: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Israel Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 215: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: UAE Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Preterm Birth and PROM Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 227: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Africa Historic Review for Preterm Birth and PROM Testing by Test Type - Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Test Type - Percentage Breakdown of Value Sales for Pelvic Exam Test, Fetal Fibronectin Test, Other Test Types, Ultrasound Test, Biochemical Markers, Uterine Monitoring Test, Nitazine Test, Ferning Test, Pooling Test, PAMG-1 Immunoassay Test and IGFBP Test for the Years 2015, 2025 & 2030
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Preterm Birth and PROM Testing by Application - PROM Application, Preterm Labor Application and Chorioamnionitis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Preterm Birth and PROM Testing by Application - Percentage Breakdown of Value Sales for PROM Application, Preterm Labor Application and Chorioamnionitis Application for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제